Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.40 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2878176 | 0.90 | — | — | |
| SCHEMBL19315826 | 0.86 | ALDH1A1 (0.44) | ALDH1A1MEN1KMT2ALMNACA12 | |
| SCHEMBL13951088 | 0.85 | ALDH1A1 (0.45) | ALDH1A1MEN1KMT2ALMNACA12 | |
| SCHEMBL605423 | 0.83 | — | — | |
| SCHEMBL12304285 | 0.83 | ALDH1A1 (0.54) | ALDH1A1MEN1KMT2ALMNACA12 | |
| SCHEMBL7074786 | 0.83 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2ALMNACA12 | |
| SCHEMBL10853286 | 0.81 | — | — | |
| SCHEMBL21676259 | 0.81 | — | — | |
| SCHEMBL13888598 | 0.81 | — | — | |
| SCHEMBL3074439 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 870 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751640-B | Galectin-3 epitope peptide, antigen, antibody and chemiluminescent kit | 南通大学附属医院 | 2026-05-15 | — | — | CN | claimed |
| CN-119751640-A | Galectin-3 epitope peptide, antigen, antibody and chemiluminescent kit | 南通大学附属医院 | 2025-04-04 | — | — | CN | claimed |
| US-20240352060-A1 | METHODS FOR THE SYNTHESIS OF PEPTOIDS USING GREEN SOLVENTS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-10-24 | — | — | US | claimed |
| CN-118812696-A | Galectin-3 epitope peptide, antigen, antibody and chemiluminescent kit | 南通大学附属医院 | 2024-10-22 | — | — | CN | claimed |
| CN-116298027-A | Liquid chromatography detection method and application of genotoxic impurities | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-20220256854-A1 | PLANT TREATMENT COMPOSITION | CRODA INTERNATIONAL PLC (GB) | 2022-08-18 | — | — | US | claimed |
| EP-3986135-A1 | PLANT TREATMENT COMPOSITION | Croda International PLC (GB) | 2022-04-27 | — | — | EP | claimed |
| US-10465334-B2 | Process for finishing textiles | ARCHROMA IP GMBH (CH) | 2019-11-05 | — | — | US | claimed |
| US-20180187369-A1 | NEW PROCESS FOR FINISHING TEXTILES | ARCHROMA IP GMBH (CH) | 2018-07-05 | — | — | US | claimed |
| EP-2491951-B1 | BLOCK COPOLYMER FOR INTRAPERITONEAL ADMINISTRATION CONTAINING ANTI-CANCER AGENT, MICELLE PREPARATION, AND CANCER THERAPEUTIC AGENT COMPRISING THE MICELLE PREPARATION AS ACTIVE INGREDIENT | NIPPON KAYAKU KK (JP) | 2017-09-20 | — | — | EP | claimed |
| US-20080275209-A1 | POLY(CARBONATE-CO-UREA) COPOLYMERS AND MELT TRANSESTERIFICATION METHOD OF PREPARING THESE COPOLYMERS | GENERAL ELECTRIC COMPANY (US) | 2008-11-06 | — | — | US | claimed |
| CN-1955175-A | Cumarin derivative and its preparation method and its drug composite and use | INST OF PHARMACEUTICAL CHINESE (CN) | 2007-05-02 | — | — | CN | claimed |
| CN-1506359-A | Coumarin amide derivative and its prepn, medicinal composition and use | �й�ҽѧ��ѧԺҩ���о��� | 2004-06-23 | — | — | CN | claimed |
| CN-1482128-A | 7-esterified and 7,20-double esterified camptothecine derivant and method for preparing the same and pharmaceutical combination and uses thereof | 中国医学科学院药物研究所 | 2004-03-17 | — | — | CN | claimed |
| CN-1467210-A | 20-esterifiable camptothecine derivative and method for making same and pharmaceutical combination and uses | 中国医学科学院药物研究所 | 2004-01-14 | — | — | CN | claimed |
| CN-1463975-A | Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof | CHINESE ACAD MED SCIENCE (CN) | 2003-12-31 | — | — | CN | claimed |
| EP-0252091-B1 | PROCESS FOR THE PREPARATION OF 3-ISOPROPYL-BENZO-2-THIA-1,3-DIAZINONE-(4)-2,2-DIOXIDE | NITROKEMIA IPARTELEPEK (HU) | 1990-11-07 | — | — | EP | claimed |
| US-4859772-A | Process for the preparation of 3-isopropyl-benzo-2-thia-1,3-diazinone-(4)-2,2-dioxide | NITRO KEMIA IPARTELEPEK (HU) | 1989-08-22 | — | — | US | claimed |
| EP-0252091-A1 | PROCESS FOR THE PREPARATION OF 3-ISOPROPYL-BENZO-2-THIA-1,3-DIAZINONE-(4)-2,2-DIOXIDE. | NITROKEMIA IPARTELEPEK (HU) | 1988-01-13 | — | — | EP | claimed |
| WO-1987003588-A1 | PROCESS FOR THE PREPARATION OF 3-ISOPROPYL-BENZO-2-THIA-1,3-DIAZINONE-(4)-2,2-DIOXIDE | NITROKÉMIA IPARTELEPEK (HU) | 1987-06-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10465334-B2 | Process for finishing textiles | ADH1C, CYP2E1, ADH1A | ALDH1A1 350/4885MEN1 1387/4885KMT2A 2431/4885 |
| US-20240352060-A1 | METHODS FOR THE SYNTHESIS OF PEPTOIDS USING GREEN SOLVENTS | QPCTL, ELOC, QPCT | ALDH1A1 3219/4885MEN1 3837/4885KMT2A 4051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.